CEBP Candidate Pathways, Whole Genome Scans: Reconciling Results, Looking into the Future Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, E. T.
Right arrow Articles by Adami, H.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, E. T.
Right arrow Articles by Adami, H.-O.
Related Collections
Right arrow Epidemiology and Prevention
Right arrow Epidemiology and Prevention: Genetics and Biomarkers
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1765-1777, October 2006
© 2006 American Association for Cancer Research


Review

The Enigmatic Epidemiology of Nasopharyngeal Carcinoma

Ellen T. Chang1,2 and Hans-Olov Adami3,4,5

1 Northern California Cancer Center, Fremont, California; 2 Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 3 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 4 Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and 5 Center for Molecular Epidemiology, National University of Singapore, Singapore

Requests for reprints: Ellen Chang, Northern California Cancer Center, 2201 Walnut Avenue, Suite 300, Fremont, CA 94538. Phone: 1-510-608-5000; Fax: 1-510-608-5085. E-mail: ellen{at}nccc.org

Nasopharyngeal carcinoma (NPC) has a unique and complex etiology that is not completely understood. Although NPC is rare in most populations, it is a leading form of cancer in a few well-defined populations, including natives of southern China, Southeast Asia, the Arctic, and the Middle East/North Africa. The distinctive racial/ethnic and geographic distribution of NPC worldwide suggests that both environmental factors and genetic traits contribute to its development. This review aims to summarize the current knowledge regarding the epidemiology of NPC and to propose new avenues of research that could help illuminate the causes and ultimately the prevention of this remarkable disease. Well-established risk factors for NPC include elevated antibody titers against the Epstein-Barr virus, consumption of salt-preserved fish, a family history of NPC, and certain human leukocyte antigen class I genotypes. Consumption of other preserved foods, tobacco smoking, and a history of chronic respiratory tract conditions may be associated with elevated NPC risk, whereas consumption of fresh fruits and vegetables and other human leukocyte antigen genotypes may be associated with decreased risk. Evidence for a causal role of various inhalants, herbal medicines, and occupational exposures is inconsistent. Other than dietary modification, no concrete preventive measures for NPC exist. Given the unresolved gaps in understanding of NPC, there is a clear need for large-scale, population-based molecular epidemiologic studies to elucidate how environmental, viral, and genetic factors interact in both the development and the prevention of this disease. (Cancer Epidemiol Biomarkers Prev 2006;15(10):1765–77)




This article has been cited by other articles:


Home page
Ann OncolHome page
C. Bosetti, J. K. McLaughlin, R. E. Tarone, E. Pira, and C. La Vecchia
Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006
Ann. Onc., January 1, 2008; 19(1): 29 - 43.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Liu, Y. Ding, W. Xie, Z. Li, X. Bai, X. Li, W. Fang, C. Ren, S. Wang, R. M. Hoffman, et al.
An Imageable Metastatic Treatment Model of Nasopharyngeal Carcinoma
Clin. Cancer Res., July 1, 2007; 13(13): 3960 - 3967.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.